NDAINJECTIONINJECTABLE
Lifecycle
Pre-Launch
Data completeness
2/8 — Basic
DEPINAR (cyanocobalamin; tannic acid; zinc acetate) by R-Pharm US is clinical pharmacology vitamin b 12 is essential to growth, cell reproduction, hematopoiesis, and nucleoprotein and myelin synthesis. Approved for anemia.
Drug data last refreshed 9h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DEPINAR is a fixed-dose combination injectable containing cyanocobalamin (vitamin B12), tannic acid, and zinc acetate indicated for anemia treatment. Cyanocobalamin is essential for cell growth, hematopoiesis, and myelin synthesis, with rapid absorption and peak plasma levels within 1 hour of intramuscular injection. The product addresses vitamin B12 deficiency-related anemias including pernicious anemia and malabsorption conditions.
Pre-Launch
Early-stage pre-launch product with undefined commercial trajectory; team size and infrastructure still being established by R-Pharm US.
Mechanism of Action
CLINICAL PHARMACOLOGY Vitamin B 12 is essential to growth, cell reproduction, hematopoiesis, and nucleoprotein and myelin synthesis. Cyanocobalamin is quantitatively and rapidly absorbed from intramuscular and subcutaneous sites of injection; the plasma level of the compound reaches its peak within…
Worked on DEPINAR at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.